Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The 2008 Lancet trial that established tesofensine's efficacy also documented cardiovascular adverse events in 18% of participants at the 1mg dose
At Weight Loss and Vitality AOD-9604 is regularly used in conjunction with a healthy eating and exercise plan showing significant improvement in the loss of body fat
[12] Gastric acid-suppressing agents (proton-pump inhibitors and H-receptor antagonists) diminish dietary B12 liberation from protein complexes, a pharmacodynamic interaction that can exacerbate underlying deficiency
Muscle weakness feels different
AOD-9604 Trial Data (Efficacy, Adverse Events) AOD-9604 was studied across six randomized, double-blind, placebo-controlled trials involving roughly 900 participants between 2001 and 2006, making it one of the more extensively studied peptide fragments in human research
US$ 24.73
US$ 29.43
US$ 25.37
